Our data support the hypothesis that the activation of Wnt/β-catenin signaling induced by exercise causes the decline of GSK-3β activity and subsequent inhibition of p-tau is a promising strategy in the treatment of brain aging or AD. The gene discussed is GSK3B; the disease is Alzheimer disease.